GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Action(s) initiated or orders passed
GLAXO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
GlaxoSmithKline Pharmaceuticals has received a tax demand order dated 30th July 2025 from the Assistant Commissioner of CGST & Central Excise, Mumbai Central, for the period April 2020 to March 2021. The order raises a GST demand of Rs. 55.90 lakh (around Rs. 55.91 lakh) on account of alleged non-payment of GST related to export of services. Interest and penalty amounts have not been quantified yet. The company received the order on 4th August 2025 and is evaluating it to decide on further action. The company has stated there is no material impact on its financial operations from this demand.
The demand amount is small relative to the company's size and management has stated no operational impact, so the immediate financial effect looks limited. However, if the company decides to contest and the demand escalates with interest and penalties, it could grow over time — worth keeping an eye on.